CD1d: at the cusp of innate and adaptive ... - Dr. Falk · PDF filebarrier-protective/...

15
Brigham & Women’s Hospital/ Harvard Medical School Edward Nieuwenhuis Arthur Kaser Stephanie Dougan Takashi Nagaishi Masaru Yoshida Yvonne van de Wal Jonathan Glickman Suzana Brozovic Sean Colgan CD1d: at the cusp of innate and adaptive immunity in regulating mucosal inflammation Inflammatory Bowel Disease—Diagnostic and Therapeutic Strategies Falk Symposium 154 June 9, 2006 Beth Israel-Deaconess Mark Exley Channing Laboratory Andrew Onderdonk Tetsuya Matsumoto Gladstone Institute Stephen Young NIH Warren Strober Ivan Fuss LIAI Mitch Kronenberg Kirin Breweries Pharmaceutical Research Laboratories SUNY Downstate Mahmood Hussain

Transcript of CD1d: at the cusp of innate and adaptive ... - Dr. Falk · PDF filebarrier-protective/...

Brigham & Women’s Hospital/Harvard Medical SchoolEdward NieuwenhuisArthur KaserStephanie DouganTakashi NagaishiMasaru YoshidaYvonne van de WalJonathan GlickmanSuzana BrozovicSean Colgan

CD1d: at the cusp of innate and adaptive immunity in regulating mucosal inflammationInflammatory Bowel Disease—Diagnostic and Therapeutic Strategies

Falk Symposium 154June 9, 2006

Beth Israel-Deaconess Mark Exley

Channing LaboratoryAndrew OnderdonkTetsuya Matsumoto

Gladstone InstituteStephen Young

NIHWarren StroberIvan Fuss

LIAIMitch Kronenberg

Kirin Breweries PharmaceuticalResearch Laboratories

SUNY DownstateMahmood Hussain

Induction of an Immune Response

Innate --

Immediate, hard-wired response between structural components of microbes and Pattern Recognition Receptorsof the immune system(e.g. peptidoglycan of bacteria⇔ NOD2 in monocytes andmacrophages → NFκB)

Adaptive (specific) --

Slower response obtained from interaction between an antigen presenting cell (DC,macrophage, B cell, IEC) and T cell that is associated with immunologic memory (e.g. nominal peptide of protein in association with MHC ⇔ T cell receptor on a T cell → Th1 or Th2 response)

Innate and AdaptiveImmune Responses Polarized Cytokine

Responses (Th1,Th2, Treg)

LeukocyteHoming/integrins(α4β7)

Tissue Destruction/Repair

CD1d, a MHC class I-related molecule on antigen presenting cells (APC) that presents glycolipids to natural killer T (NKT) cells for the regulation of

immune responses

αGalCer

αGalCer (α-galactosylceramide): a model glycolipid antigen

NKT cell

IFN-γIL-2

IL-4IL-5IL-13

Chemokines

Invariant TCR-α(Vα14-Jα18) chain

APCDC, Mφ, B cell,Hepatocyte,

IEC

CD1d

β2-microglobulin (β2m)

Th1

Th2

adapted from Nature Rev Immunology 2002;2:557

Intestinal Inflammation

T

Th2Th1

Microbiota/Dietary

Epithelium

Dendritic cells

Effector memoryT cell

Differentiated T cells

CytokinesIFN-γ ,TNF-α IL4,5,10,13

Microbial Colonization

IL-12 IL-4Differentiating factors—

Innate ImmuneSystem

Foreign(or host)glycolipids ?

Antigenpresenting

cell

CD1d

αGalCer

EBI3(IL-12-like)

NKT

IFN-γ, IL4,10,13

“Frontiers of the Immune System”

Heller et al Immunity, 2002; Nieuwenhuis et al PNAS, 2004

CD1d

UC

CD1d

ImmuneMediatedDiseases

AlveolarMΦ

MIP-2

CXCR2PMN

PseudomonasAirway Lumen NKT

IFN-γ

Immediate

Delayed

CD1d

DC

Nieuwenhuis E et al, Nature Med 2002

NKT

NKT

CD1 and CD1-restricted T cells mediate anendogenous pathway of antimicrobial defense

at the mucosal surface of the lung due to ability torecruit PMNs and activate macrophages

3 6 12 24 48 72

104

105

106

107

108

109

1010

CFU/g

<102

103

CD1d KO mice

Hours after innoculation

, P<0.05*

*

* * *

CD1d KO

Wild-type

Germ-free CD1d-deficient miceexhibit a major defect in early

colonization with E. coli §

§ E.coli strain ATCC 25922

105

106

107

108

1010

Jejunum Ileum Cecum Colon

PBSαGalCerCF

U/g

*: P<0.05109

104

103

102 ** **

**: P<0.01

**

αGalCer Treatment Prevents Mucosalcolonization of the intestine with E. coli

in germ-free wild-type mice

104

105

106

107

108

109

1010

Jejunum Ileum Cecum Colon

CD1 KO miceWild type mice

Viable E. coli in intestines of germ-freeCD1d-deficient mice and wild type micefour days after colonization suggests

a small intestinal defectCF

U/g

: P<0.05*

*

Altered ultrastructure of Paneth-granules in germ-free, CD1d-deficient mice

Wild Type CD1d-KO

Diminished degranulation of Paneth Cellsupon colonization with E. Coli in

germ free CD1d-/- mice

YXXZP

CD1d

IFN-γ IL-10X

YXXZ

IEL

YXXZ

NKT

Lumen

Serosa

Retrograde Signalling of CD1d on intestinalEpithelial Cells induces IL-10 secretion

P

Proc Natl Acad Sci USA 1999;96:13938; Gastroenterology 2003;124:1420;J Clin Invest 2004;113:1490; Nature Med 2004;10:535; J Exp Med 2005;202:529

MTP*

*MTP (microsomal triglyceridetransfer protein)

phospholipid

*24.7 NKT cell hybridoma; ND = not detectable

0102030405060708090

100

MODE-KMODE-KNKT

MODE-KNKT

αGalCer

IL-1

0 (p

g/m

l)

MODE-KNKT

αGalCeranti-CD1d

MODE-KNKT

αGalCerIgG2b

NKT cells* induce CD1d-restricted IL-10 secretion by MODE-K absorptive epithelial

cell line

020406080

100120140

MODE-K MODE-KNKT

MODE-KNKT

αGalCer

IL-1

0 (p

g/m

l) IL-10 siRNA

Control siRNA

ND

αGalCer

NKT cellMODE-K(IEC)

CD1d

anti-CD1d

SilenceIL-10

production

iNKT

Difference in retrograde CD1d signaling in dendritic cells and epithelial cells –

CD1d induces IL-12 from DC

0102030405060708090

100

Dendritic cell Dendritic cellNKT

Dendritic cellNKTαGC

IL-1

0 (p

g/m

l)

0100200300400500600700800

IL-1

2 (p

g/m

l)

Dendritic cell Dendritic cellNKT

Dendritic cellNKTαGC

ND ND ND

ND = not detectable

APC CD1d

TCR

barrier-protective/anti-microbial/anti-inflammatory

IL-10 (IEC)Defensins (Paneth Cells)

pro-inflammatoryIL-12 (from DC)

MTP

NKT cells regulate multiple different biologicalpathways in mucosal tissues by interactionswith discrete antigen presenting cell types

MTP

CD1dIL-10

Defensins

IL-12EBI3?

IL-13n = 45P<0.001

MTP KO

Wild-type

0

20

40

60

80

100

0 1 2 3 4days

Surv

ival

(%)

MTP

Therapeutic implications:•Target end-products• Differences in cell types

(ligands, theircellular quantities/qualities)